Director/PDMR Shareholding

By

Regulatory News | 19 Feb, 2018

Updated : 15:52

RNS Number : 3100F
UDG Healthcare Public Limited Co.
19 February 2018
 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Liam Logue

 

 

 

Reason for the notification

 

a)

Position/status

Head of Corporate Development  - UDG Healthcare plc

 

b)

Initial Notification Amendment

Initial Notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

UDG Healthcare plc

 

b)

LEI

549300IWG5ZPP6B8HH13

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary Shares of €0.05 each in UDG Healthcare plc

 

ISIN: IE0033024807

b)

Nature of the transaction  

(i)            Exercise of share options

(ii)           Sale of shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

(i)            €0.05

(ii)           £8.15

113,249  Ordinary Shares

113,249 Ordinary Shares

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

2018-02-15

 

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 

 

g)

Additional Information

 

 

 

 

 

 

 

 

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Liam Logue

 

 

 

Reason for the notification

 

a)

Position/status

Head of Corporate Development  - UDG Healthcare plc

 

b)

Initial Notification Amendment

Initial Notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

UDG Healthcare plc

 

b)

LEI

549300IWG5ZPP6B8HH13

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary Shares of €0.05 each in UDG Healthcare plc

 

ISIN: IE0033024807

b)

Nature of the transaction  

(iii)          Exercise of share options

(iv)          Sale of shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

(iii)          €0.05

(iv)          £8.205

2,646  Ordinary Shares

2,646 Ordinary Shares

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

2018-02-16

 

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 

 

g)

Additional Information

 

 

 

 

 

 

 

 

 

 

 

Contact:

Damien Moynagh

General Counsel & Company Secretary

Tel: +353-1-4689000

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFEEFIIALIT

Last news